Lack of association between TREM-1 gene polymorphisms and severe sepsis in a Chinese Han population

Human Immunology

Volumn 69, Issue 3, 2008, Pages 220-226

  Chen, QiXing ^a,b   Zhou, HuiDan ^b,c   Wu, ShuiJing ^b   Wang, HaiHong ^b   Lv, Chen ^b   Cheng, BaoLi ^b   Xie, GuoHao ^b   Fang, XiangMing ^b  

^a BEIJING HOSPITAL   (China)

^b First Affiliated Hospital   (China)

^c ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

Association study; Chinese; Severe sepsis; SNPs; TREM 1

Indexed keywords

CELL SURFACE RECEPTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ADULT; AGED; ARTICLE; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; SEPSIS; SURVIVAL; TREM 1 GENE;

CHINA; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INHERITANCE PATTERNS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; SEPSIS;

EID: 41549140539     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.01.013     Document Type: Article

References (29)

1. Martin G.S., Mannino D.M., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003) 1546
2. Vincent J.L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 34 (2006) 344
3. Cheng B., Xie G., Yao S., Wu X., Guo Q., Gu M., et al. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit Care Med 35 (2007) 2538
4. Cohen J. The immunopathogenesis of sepsis. Nature 420 (2002) 885
5. Annane D., Bellissant E., and Cavaillon J.M. Septic shock. Lancet 365 (2005) 63
6. Russell J.A. Management of sepsis. N Engl J Med 355 (2006) 1699
7. Hotchkiss R.S., and Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 348 (2003) 138
8. Bouchon A., Dietrich J., and Colonna M. Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164 (2000) 4991
9. Klesney-Tait J., Turnbull I.R., and Colonna M. The TREM receptor family and signal integration. Nat Immunol 7 (2006) 1266
10. Bleharski J.R., Kiessler V., Buonsanti C., Sieling P.A., Stenger S., Colonna M., et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol 170 (2003) 3812
11. Bouchon A., Facchetti F., Weigand M.A., and Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410 (2001) 1103
12. Knapp S., Gibot S., de Vos A., Versteeg H.H., Colonna M., and van der Poll T. Cutting edge: Expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J Immunol 173 (2004) 7131
13. Gibot S., cravoisy A., Kolopp-Sarda M.N., Béné M.C., Faure G., Bollaert P.E., et al. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 33 (2005) 792
14. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 (1992) 864
15. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. SCCM/ESICM/ACCP/ATS/SIS, 2001SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31 (2003) 1250
16. Sole X., Guino E., Valls J., Iniesta R., and Moreno V. SNPStats: A web tool for the analysis of association studies. Bioinformatics 22 (2006) 1928
17. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263
18. Dupont W.D., and Plummer W.D. PS power and sample size program available for free on the Internet. Control Clin Trials 19 (1998) 589
19. Lin M.T., and Albertson T.E. Genomic polymorphisms in sepsis. Crit Care Med 32 (2004) 569
20. Cobb J.P., and O'Keefe G.E. Injury research in the genomic era. Lancet 363 (2004) 2076
21. Michalek J., Svetlikova P., Fedora M., Klimovic M., Klapacova L., Bartosova D., et al. Interleukin-6 gene variants and the risk of sepsis development in children. Hum Immunol 68 (2007) 756
22. Michalek J., Svetlikova P., Fedora M., Klimovic M., Klapacova L., Bartosova D., et al. Bactericidal permeability increasing protein gene variants in children with sepsis. Intensive Care Med 33 (2007) 2158
23. Chen Q.X., Lv C., Huang L.X., Cheng B.L., Xie G.H., Wu S.J., et al. Genomic variations within DEFB1 are associated with the susceptibility to and the fatal outcome of severe sepsis in Chinese Han population. Genes Immun 8 (2007) 439
24. Walley K.R., and Russell J.A. Protein C -1641 AA is associated with decreased survival and more organ dysfunction in severe sepsis. Crit Care Med 35 (2007) 12
25. Arcaroli J., Silva E., Maloney J.P., He Q., Svetkauskaite D., Murphy J.R., et al. Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis. Am J Respir Crit Care Med 173 (2006) 1335
26. Lorenz E., Mira J.P., Frees K.L., and Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162 (2002) 1028
27. Barber R.C., Aragaki C.C., Rivera-Chavez F.A., Purdue G.F., Hunt J.L., and Horton J.W. TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 41 (2004) 808
28. Agnese D.M., Calvano J.E., Hahm S.J., Coyle S.M., Corbett S.A., Calvano S.E., et al. Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 186 (2002) 1522
29. Ioannidis J.P. Genetic associations: False or true?. Trends Mol Med 9 (2003) 135